Abstract
Recently, an inhibitory role of dopamine (DA) and DA agonist on LH as well as prolactin (PRL) release has been demonstrated. Furthermore, it is reported that a lowering of LH and FSH plasma levels was induced according to a selective acceleration in DA turnover in the hypothalamus by oestradiol administration. In this study, we investigated the role of DA agonist on plasma LH, FSH and prolactin release following oestrogen treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
